Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 3
2006 2
2007 5
2008 6
2009 8
2010 2
2011 4
2012 4
2013 4
2014 4
2015 4
2016 7
2017 5
2018 3
2019 3
2020 6
2021 13
2022 12
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries.
Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, Lascarrou JB, Szuldrzynski K, Camporota L, Pelosi P, Sorbello M, Higgs A, Greif R, Putensen C, Agvald-Öhman C, Chalkias A, Bokums K, Brewster D, Rossi E, Fumagalli R, Pesenti A, Foti G, Bellani G; INTUBE Study Investigators. Russotto V, et al. Among authors: rossi e. JAMA. 2021 Mar 23;325(12):1164-1172. doi: 10.1001/jama.2021.1727. JAMA. 2021. PMID: 33755076 Free PMC article.
Current challenges in HER2-positive breast cancer.
Puglisi F, Fontanella C, Amoroso V, Bianchi GV, Bisagni G, Falci C, Fontana A, Generali D, Gianni L, Grassadonia A, Moscetti L, Portarena I, Rossi E, Marchetti P. Puglisi F, et al. Among authors: rossi e. Crit Rev Oncol Hematol. 2016 Feb;98:211-21. doi: 10.1016/j.critrevonc.2015.10.016. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26638862 Free article. Review.
Alzheimer's disease: another target for heparin therapy.
Bergamaschini L, Rossi E, Vergani C, De Simoni MG. Bergamaschini L, et al. Among authors: rossi e. ScientificWorldJournal. 2009 Sep 1;9:891-908. doi: 10.1100/tsw.2009.100. ScientificWorldJournal. 2009. PMID: 19734963 Free PMC article. Review.
The PI3k inhibitors: new hopes in the battle against advanced NSCLC.
Sacco PC, Maione P, Rossi A, Barecshino MA, Sgambato A, Casaluce F, Napolitano A, Palazzolo G, Rossi E, Ferrara C, Gridelli C. Sacco PC, et al. Among authors: rossi e. Front Biosci (Landmark Ed). 2014 Jan 1;19(2):259-71. doi: 10.2741/4205. Front Biosci (Landmark Ed). 2014. PMID: 24389182 Free article. Review.
A multidisciplinary approach to screen the post-COVID-19 conditions.
Squillace N, Cogliandro V, Rossi E, Bellelli G, Pozzi M, Luppi F, Lettino M, Strepparava MG, Ferrarese C, Pollastri E, Ricci E, Bonfanti P; STORM Long-COVID Team. Squillace N, et al. Among authors: rossi e. BMC Infect Dis. 2023 Jan 24;23(1):54. doi: 10.1186/s12879-023-08006-4. BMC Infect Dis. 2023. PMID: 36694110 Free PMC article.
Management of unfit older patients with advanced NSCLC.
Gridelli C, Maione P, Rossi A, Palazzolo G, Colantuoni G, Rossi E. Gridelli C, et al. Among authors: rossi e. Cancer Treat Rev. 2009 Oct;35(6):517-21. doi: 10.1016/j.ctrv.2009.04.011. Epub 2009 May 19. Cancer Treat Rev. 2009. PMID: 19457617 Review.
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Gridelli C, Maione P, Rossi A, Falanga M, Bareschino M, Schettino C, Colantuoni G, Guerriero C, Nicolella D, Rossi E, Ferrara ML, Palazzolo G. Gridelli C, et al. Among authors: rossi e. Expert Rev Anticancer Ther. 2009 Jan;9(1):115-24. doi: 10.1586/14737140.9.1.115. Expert Rev Anticancer Ther. 2009. PMID: 19105711 Review.
88 results